813 Results
Sort By:
Published on November 14, 2016
Mayo Clinic has announced a bioinformatics collaboration that will leverage the workflow tracking and laboratory integration tool BaseSpace Clarity LIMS from Illumina, intended to improve and streamline Mayo’s next-generation sequencing capabilities. The pilot program will integrate existing services and software at Mayo to improve workflows for researching inherited diseases while…
Published on October 26, 2016
Twenty academic institutions, diagnostic and drug developers, and government agencies have begun creating an open database for liquid biopsy data—a pilot project of Vice President Joe Biden’s “Cancer Moonshot”—aimed at advancing development of blood profiling diagnostic technologies. The Blood Profiling Atlas pilot plans to aggregate, make freely available, and harmonize…
Published on October 20, 2016
Next-generation DNA sequencing service provider Floragenex and point-of-care diagnostics company Sedia Bioscience announced they have merged, Through the merger the companies aim to create a combined provider of genomic services for scientific customers as well as testing solutions for human immunodeficiency virus (HIV) and other infectious agents. Details of the…
Published on September 8, 2016
Developers of genetic tests marketed wholly or partially direct to consumers (DTC) initially looked to selling tests for growth, then to monetizing data collected from those tests. Recent announcements, however, suggest a third monetization model for personal genetics—applying tests and their data to research and clinical studies. Credence Research projects…
Published on August 24, 2016
A new collaborative study from more than twenty pediatric emergency departments around the U.S. has described results for measuring patterns of RNA expression from blood samples that can enable clinicians to distinguish bacterial infections from other causes of fever in infants up to two months old. The findings from the…
Published on August 2, 2016
A new study has uncovered 17 genetic variations that are linked to depression at 15 genomic loci. Customers of 23andMe, a genetic testing service, contributed their data to a large-scale study of depression, allowing the study to succeed where earlier, smaller, and more conventional studies failed. The new study has…
Published on July 8, 2016
New research published in Cell using a big data approach to compare mutations in cancer cell lines with those found in patient tumor samples is providing a new avenue of inquiry for researchers seeking to develop new, more precise drugs for the treatment of cancer. The report, “A Landscape of…
Published on June 7, 2016
It is often said that “the proof is in the pudding” and clinical research is no exception. For years, scientists and physicians have postulated that personalized therapeutic approaches hold the key to efficiently thwarting diseases like cancer. Yet, as a scientific endeavor, researchers are rightfully required to perform due diligence…
Published on June 2, 2016
The results from a unique new pilot program conducted by scientists from the Icahn School of Medicine at Mount Sinai show that multidimensional genomic profiles outperform the targeted cancer panels used currently in many clinical laboratories. The Mt. Sinai team developed and tested the personalized cancer therapy program using an…
Published on June 2, 2016
With $215 million in funding, the federal government’s Precision Medicine Initiative® is expected to generate the scientific evidence needed to move personalized medicine into clinical practice by providing clinicians with the knowledge and tools to determine more precise medical treatment. One objective of the initiative is to accelerate pharmacogenomics (PGx),…
Published on May 18, 2016
With the rapid rise in genomic profiling and molecular analysis of varying degrees of cancerous tumors, there has been an exponential explosion of clinical data being gathered. Researchers have not only struggled with how to store and interpret this digital information but arguably, more importantly, have been searching for ways…
Published on May 5, 2016
Scientists at Loyola University have identified a tumor gene that they believe may help predict survival outcomes in patients with cancer of the mouth and tongue—or squamous cell carcinoma. The Loyola team wanted to tackle underlying issues associated with mouth cancers and addressed the problem by “reanalyzing publicly available genomic…
Published on April 25, 2016
Stephen Kingsmore, M.D., D.Sc., president and CEO of Rady Children’s Institute for Genomic Medicine at Rady Children’s Hospital-San Diego, now holds the official Guinness World Records® designation for the fastest genetic diagnosis, for the results that he and clinicians published just seven months ago. The feat is being recognized today at…
Published on April 4, 2016
Sunquest Information Systems said today it has acquired GeneInsight for an undisclosed price, in a deal designed to advance the buyer’s clinical genetics IT platform. The acquisition comes 2 years after Sunquest made a strategic investment in GeneInsight, an IT company that streamlines the analysis, interpretation, and reporting of complex…
Published on March 1, 2016
The influence that the polymerase chain reaction (PCR) has had on modern molecular biology is nothing short of remarkable. This technique, which is akin to molecular photocopying, has been the centerpiece of everything from the OJ Simpson Trial to the completion of the Human Genome Project. Clinical laboratories use this…